EMED
Electromedical Technologies, IncCompany Information
- Company Name
- Electromedical Technologies, Inc
- CIK
- CIK0001715819
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- EMED: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- EMED
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2021-07-08
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 465,450
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2024-11-19
- Price on filing date
- —
- 1-month reaction
- 0.00%
- 3-month reaction
- -50.00%
Balance Sheet
Values in millions ($)| Line item | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Series B Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 1 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | - | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities And Other Liabilities | - | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | ||||||
| Contract With Customer Liability Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 4 | 4 | 4 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 2 | 1 | ||||||
| Loans Payable To Bank Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Finance Lease Liability Current | - | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Convertible Debt Current | 1 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Derivative Liabilities Current | 1 | 1 | 1 | 1 | 0 | 1 | - | - | - | - | - | - | ||||||
| Long Term Loans From Bank | - | - | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Other Loans Payable Long Term | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finance Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 4 | 3 | 2 | 3 | 2 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 24 | 24 | 24 | 24 | 24 | 24 | 23 | 22 | 22 | 21 | 20 | 21 | ||||||
| Stockholders Equity | -4 | -3 | -4 | -3 | -3 | -2 | -1 | -2 | -2 | -1 | -2 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -29 | -28 | -28 | -27 | -27 | -27 | -25 | -25 | -24 | -23 | -22 | -22 | ||||||
| Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 5,000 | 5,000 | 1,999 | 1,999 | 1,999 | 1,999 | 1,999 | 999 | 999 | 500 | 500 | 250 | ||||||
| Shares Outstanding | 725 | 566 | 486 | 463 | 471 | 432 | 297 | 190 | 158 | 142 | 105 | 88 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialElectromedical Technologies, Inc (EMED) — SEC Financial Statements & Analysis
Electromedical Technologies, Inc (EMED) is a surgical & medical instruments & apparatus company, incorporated in DE. Electromedical Technologies, Inc trades on OTC as: EMED. Electromedical Technologies, Inc (EMED)'s most recent SEC filing is a Form 10-Q for the period ended 2024-09-30, filed with the SEC on 2024-11-19. Based on that filing, Electromedical Technologies, Inc carries a market cap of $340.50K, a P/E ratio of -0.20x, a P/B ratio of -0.09x, a P/S ratio of 0.37x, an enterprise value of $1.70M, and an EV/EBITDA multiple of -1.68x. On profitability, it posts a gross margin of 75.08%, an operating margin of -109.62%, a net margin of -182.41%, a Return on Equity (ROE) of 51.58%, and a Return on Assets (ROA) of -236.50%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -35.09% year-over-year, net income growth of -47.62% year-over-year, and EPS growth of -64.14% year-over-year. On the balance sheet, it maintains a current ratio of 0.07x, a quick ratio of 0.01x, working capital of $-4.05M, a debt-to-equity ratio of -1.14x, a debt ratio of 8.04, an interest coverage ratio of -4.38x, free cash flow of $-131.21K (TTM), and net debt of $1.36M. Figures sourced from SEC EDGAR.
- Market Cap
- $340.50K
- P/E TTM
- -0.20x
- EPS TTM
- $-0.00
- P/B TTM
- -0.09x
- ROE TTM
- 51.58%
- ROA TTM
- -236.50%
- Debt To Equity
- -1.14x
- Free Cash Flow TTM
- $-131.21K
- Net Revenue TTM Growth 1Y
- -35.09%
Data as of 2024-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Electromedical Technologies, Inc in?
Electromedical Technologies, Inc (EMED) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does EMED trade on?
Electromedical Technologies, Inc (EMED) trades on the OTC.
Where is Electromedical Technologies, Inc incorporated?
Electromedical Technologies, Inc is incorporated in DE.
When was Electromedical Technologies, Inc (EMED)'s most recent SEC filing?
Electromedical Technologies, Inc (EMED)'s most recent SEC filing is a Form 10-Q for the period ended 2024-09-30, filed with the SEC on 2024-11-19.
What is EMED's market cap?
Electromedical Technologies, Inc (EMED) has a market capitalization of $340.50K as of 2024-09-30.
What is EMED's EPS (earnings per share)?
Electromedical Technologies, Inc (EMED)'s trailing twelve month EPS is $-0.00 as of 2024-09-30.
What is EMED's ROE (return on equity)?
Electromedical Technologies, Inc (EMED)'s trailing twelve month Return on Equity (ROE) is 51.58% as of 2024-09-30.
What is EMED's ROA (return on assets)?
Electromedical Technologies, Inc (EMED)'s trailing twelve month Return on Assets (ROA) is -236.50% as of 2024-09-30.
What is EMED's EV/EBITDA?
Electromedical Technologies, Inc (EMED)'s trailing twelve month EV/EBITDA is -1.68x as of 2024-09-30.